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The HIV-1 protein Rev regulates the cytoplasmic levels of incompletely spliced HIV-1 mRNAs. The plasmid pSVc21, which
contains a HIV-1 provirus, was introduced into COS cells by transient transfection. Simultaneous detection of HIV-1 RNAs and
Rev proteins produced in transfected cells was then performed in order to determine the relative distribution of these two
components. HIV-1 RNAs and the Rev protein localized to the same areas of the nucleoplasm, implying that these locations
represent sites where Rev interacts with its target RNAs. Using a monoclonal antibody targeted to the splicing factor SC-35
it was demonstrated that the sites where HIV-1 mRNAs and Rev were detected often contained weak anti-SC-35 staining,
whereas little RNA and Rev were found in strongly labeled SC-35-containing speckles. The same distribution of HIV-1 RNAs
relative to SC-35 was also seen in transfected HeLa cells and in primary human lymphocytes infected with HIV-1 primary
isolates. In addition, transiently expressed intron-containing b-globin RNAs were shown to distribute to weak anti-SC-35
staining in a manner similar to that of HIV-1 RNAs. The findings suggest that Rev and HIV-1 RNAs interact at putative sites
of mRNA transcription and splicing. © 1998 Academic Press
INTRODUCTION
Different sets of HIV-1 proteins are produced from
unspliced, partially spliced, and completely spliced
forms of a single pre-mRNA transcript. Unspliced and
partially spliced RNAs require the HIV-1 protein Rev in
order to be transported to the cytoplasm, while com-
pletely spliced HIV-1 RNAs appear in the cytoplasm in-
dependently of Rev (Emerman et al., 1989; Felber et al.,
1989; Hammarskj¨old et al., 1989; Malim et al., 1988). Rev
is produced from completely spliced RNAs early after the
onset of viral transcription and localizes to the nuclei in
order to mediate transport of unspliced and partially
spliced RNAs (Cullen, 1995).
Rev is capable of binding specifically to a sequence
element termed the Rev responsive element (RRE) which
is present in unspliced and partially spliced HIV-1 RNAs
(Daly et al., 1989; Heaphy et al., 1990; Malim et al., 1990;
Zapp and Green, 1989). It has also been demonstrated
that Rev contains a nuclear export signal (Meyer and
Malim, 1994; Szilvay et al., 1995; Wolff et al., 1995) as well
as a nuclear import signal (Malim et al., 1989a), making
it capable of shuttling between the nuclei and the cyto-
plasm (Kalland et al., 1994a; Meyer and Malim, 1994). It is
therefore possible that Rev functions by binding to RRE-
containing RNAs present in the nuclei and subsequently
directs these RNAs through a nuclear export pathway.
Interaction between Rev and its target RNAs may take
place in the context of a splicing complex. Support for
this comes from studies which show that Rev interacts
with components of the splicing machinery and that
HIV-1 pre-mRNAs contain inefficient splice sites which
may serve to slow down splicing and to provide optimal
conditions for Rev function (Chang and Sharp, 1989;
Hammarskj¨old et al., 1994; Lu et al., 1990; Stutz and
Rosbash, 1994). An alternative model which has been
proposed is that incompletely spliced HIV-1 RNAs are
retained in the nuclei due to the presence of cis-acting
repressive sequence (CRS) elements (Cochrane et al.,
1991; Maldarelli et al., 1991; Nasioulas et al., 1994; Rosen
et al., 1988; Schwartz et al., 1992). Recent studies have
suggested that such CRS elements may function by
directing incompletely spliced HIV-1 RNAs away from the
splicing apparatus and into a pool of RNAs which is
accessible for Rev (Berthold and Maldarelli, 1996; Mikae-
lian et al., 1996).
Components of the splicing machinery mainly concen-
trate in two distinct ultrastructural nuclear domains
termed perichromatin fibrils (PFs) and interchromatin
granule clusters (IGCs) (Fakan et al., 1984; Fakan and
Puvion, 1980; Spector, 1993). PFs have been suggested
to represent sites where RNA transcription occurs, since
newly transcribed RNA pulse labeled with tritium has
been detected in these domains. IGCs, on the other
hand, generally do not contain newly transcribed RNA
and have been proposed to function as storage or as-
sembly sites for splicing complexes (Bachellerie et al.,
1975; Fakan, 1994; Fakan and Bernhard, 1971; Fakan and
Nobis, 1978). Using fluorescently labeled probes IGCs
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can be viewed in the light microscope as 20 to 50
nuclear domains termed speckles (Carmo-Fonseca et
al., 1992; Fu and Maniatis, 1990; Nyman et al., 1986;
Reuter et al., 1984; Spector, 1984). An antibody commonly
used to label speckles is the anti-SC-35 Mab, which
binds to the non-snRNP splicing factor SC-35 (Fu and
Maniatis, 1990). Fluorescent staining of Br–UTP-labeled
RNA has shown that nascent RNA polymerase II (RPII)
transcripts mainly distribute outside the anti-SC-35-la-
beled speckles in areas containing weakly labeled
SC-35 (Wansink et al., 1993), while specific cellular pre-
mRNAs and transcriptionally active genes have been
localized to the periphery of speckles (Huang and Spec-
tor, 1991; Xing et al., 1993, 1995).
Several studies have indicated that Rev and splicing
factors are distributed nonrandomly relative to each
other. In one study, in which methanol-fixed cells were
used, Rev was observed to colocalize with splicing fac-
tors in a speckled pattern in the nuclei (Kalland et al.,
1994b). In more recent studies in which aldehyde fixation
has been employed, Rev has been detected on the out-
side or at the periphery of SC-35-containing speckles
(Berthold and Maldarelli, 1996; Dundr et al., 1995; Luznik
et al., 1995).
Several studies have also been performed in order to
determine the subcellular localization of HIV-1 RNAs
(Berthold and Maldarelli, 1996; D’Agostino et al., 1992; Law-
rence et al., 1991, 1990; Zhang et al., 1996). In two recent
reports the nuclear localization of incompletely spliced
HIV-1 RNAs was compared to the localization of SC-35-
containing speckles (Berthold and Maldarelli, 1996; Zhang
et al., 1996). In these studies no relation between incom-
pletely spliced HIV-1 RNAs and SC-35 was found. However,
the pool of splicing factors present in between speckles
was not considered in those studies.
In the present study a newly developed protocol for
simultaneous detection of RNAs and proteins was used in
order to directly compare the subcellular localization of
HIV-1 RNAs and Rev. These experiments demonstrated that
HIV-1 RNAs and the Rev protein localize to the same areas
of the nucleoplasm (throughout this article the nucleoli will
be considered a compartment separate from the nucleo-
plasm). Using the same in situ labeling procedure the
localization of HIV-1 RNAs in virus-producing cells was also
compared to anti-SC-35 staining. This revealed a nonran-
dom relationship between these two components where
HIV-1 RNAs frequently localized to areas containing weakly
labeled SC-35, while little RNA was detected in strongly
labeled speckles.
Results
The plasmid pSVc21 (which contains the HIV-1 HXBc2
provirus) and the plasmid pSVc21B (which is a rev minus
derivative of pSVc21 containing a frame shift mutation in
the rev gene) were used to transfect the monkey kidney
cell line COS. At 28 to 40 h after transfection the cells
were fixed in paraformaldehyde and the subcellular lo-
calization of HIV-1 RNAs was determined using immuno-
fluorescent in situ hybridization. Two different digoxige-
nin-labeled probes were used: The intron probe, which is
complementary to a nucleotide sequence present in the
env region of HIV-1 RNAs, and the exon probe, which is
complementary to the rev sequence in completely
spliced HIV-1 mRNAs (Fig. 1). The intron probe is ex-
pected to hybridize only to unspliced and partially
spliced HIV-1 RNAs, while the exon probe has the po-
tential to hybridize to all HIV-1 mRNA species. The exon
probe does not, however, contain nucleotide sequences
which are complementary to excised intron RNAs.
Using the intron probe it was demonstrated that in-
completely spliced HIV-1 RNAs efficiently were trans-
ported to the cytoplasm in cells containing the plasmid
pSVc21 (Figs. 2A and 2B), whereas these RNAs were
retained in the nuclei of cells transfected with the rev-
deficient plasmid pSVc21B (Figs. 2E and 2F). This is
consistent with previous studies showing that nucleocy-
toplasmic transport of incompletely spliced HIV-1 RNAs
requires the presence of a functional Rev protein
(Berthold and Maldarelli, 1996; Emerman et al., 1989;
Felber et al., 1989; Hammarskj¨old et al., 1989; Malim et
al., 1989a,b; Zhang et al., 1996). Using the exon probe,
RNA staining also was detected in the cytoplasm of
pSVc21B-transfected cells (Figs. 2C and 2D), indicating
that completely spliced forms of HIV-1 RNAs were pro-
duced and transported to the cytoplasm in these cells.
The nuclear staining detected by the intron probe and
the exon probes in pSVc21B-transfected cells differed in
that the staining detected by the intron probe was more
intense and abundant (compare panels E and G in Fig.
2). However, no apparent differences in staining patterns
were discovered for the two probes in cells transfected
with pSVc21.
FIG. 1. Schematic of RNA probes used for in situ hybridization. The 39
half of the HIV-1 genome is shown. The regions spanned by the intron
and exon probes are indicated below. The intron probe was in vitro
transcribed from a plasmid containing a HIV-1 fragment spanning the
entire rev/tat intron sequence. This probe was predicted to hybridize to
unspliced and partially spliced HIV-1 mRNAs but not to completely
spliced HIV-1 mRNAs. The exon probe was in vitro transcribed from a
plasmid containing the rev cDNA sequence. This probe was predicted
to hybridize to all HIV-1 mRNAs but not to intron sequences which are
excised from HIV-1 mRNAs by splicing. SD, splice donor; SA, splice
acceptor.
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Double labeling of HIV-1 RNAs and Rev
In order to compare the subcellular localization of
Rev and HIV-1 RNAs, pSVc21-transfected cells were
double labeled using the HIV-1-specific probes and
the 8E7 Mab which binds to the Rev protein. Previous
work has shown that the 8E7 Mab is capable of de-
tecting Rev in several different cellular compartments,
including the nucleoli, the nucleoplasm, and the cyto-
plasm (Kalland et al., 1994a,b; Szilvay et al., 1995). It
has also been noted that the relative distribution of
Rev staining among these compartments varies con-
siderably among individual Rev producing cells (Kal-
land et al., 1994a,b). The 8E7 Mab staining which was
detected in transfected COS cells after in situ hybrid-
ization showed a similar variable subcellular distribu-
tion. Although the localization of Rev varied among
individual cells, the anti-Rev staining consistently ac-
cumulated in the same areas of the nucleoplasm as
the HIV-1 RNA staining (Fig. 3). No differences in the
distribution relative to anti-Rev staining were detected
for the intron and the exon probes (Fig. 3).
No apparent colocalization between Rev and RNA
was seen in the cytoplasm. It was noted, however, that
the same cells which contained strong labeling of RNA
in the cytoplasm also often contained strong cytoplas-
mic Rev staining (data not shown). Furthermore, in
some of the transfected cells RNA and Rev was de-
tected at or near the nuclear membrane (data not
shown). This staining may represent Rev and RNAs
which are present in nuclear pore complexes.
In the majority of transfected cells examined the Rev
staining concentrated at the periphery of the nucleoli
(Fig. 3). This nucleolar staining pattern is not particular
for pSVc21-transfected COS cells, as a similar nucleolar
staining pattern has been noted in other cell lines both in
the absence and in the presence of RRE-containing
RNAs (data not shown). The reason for this staining
pattern is not clear. One possibility may be that the
antibody used to detect Rev does not efficiently pene-
trate into the interior of this compartment. Alternatively,
the Rev protein may have been lost from the nucleoli
during the fixation procedure. The extent of peripheral
Rev staining in the nucleoli varied among transfected
cells, whereas individual nucleoli within a single cell
generally exhibited a similar staining pattern (see Fig. 3).
The nucleolar staining pattern did not differ dramatically
from experiment to experiment.
No cross-reactivity was seen between antibodies
used to detect Rev and antibodies used to detect digoxi-
genin-labeled probes. This was best exemplified by the
observation that no Rev staining was detected when
double labeling was performed on cells transfected with
pSVc21B (data not shown) and that large amounts of Rev
were visualized in the nucleoli, whereas virtually no cor-
responding RNA signal was seen in this compartment
(Fig. 3). The Rev staining pattern seen in cells which had
been subjected to in situ hybridization exhibited a distri-
bution which was similar to that seen in cells subjected
to indirect immunofluorescence without prior in situ hy-
bridization (not shown).
Double-labeling of HIV-1 RNAs and SC-35
Several factors involved in pre-mRNA splicing have
been shown to concentrate in 20 to 50 distinct domains
FIG. 2. In situ labeling of HIV-1 RNAs produced in transiently trans-
fected COS cells. COS cells transfected with pSVc21 (rev1) or pSVc21B
(rev2) were fixed in paraformaldehyde and subjected to in situ hybrid-
ization using the HIV-1-specific probes. Immunofluorescent micro-
scope images are shown in A, C, E, and G, while the corresponding
phase contrast images are shown in B, D, F, and H. Arrows point to the
nuclei of transfected cells. The probes used for in situ hybridization are
indicated. IP, intron probe; EP, exon probe.
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in the nuclei termed speckles (Carmo-Fonseca et al.,
1992; Fu and Maniatis, 1990; Nyman et al., 1986; Reuter
et al., 1984; Spector, 1984). An antibody commonly used
to label speckles is the anti-SC-35 Mab, which binds to
a phosphorylated epitope within the serine/arginine (SR)
domain of the non-snRNP splicing factor SC-35 (Fu and
Maniatis, 1990). In addition to labeling speckles, the
anti-SC-35 Mab also stains a weaker pattern in between
FIG. 5. Expression of HIV-1 RNAs and b-globin RNAs in COS cells induces redistribution of SC-35. Confocal micrographs of COS cells expressing HIV-1
RNAs from the plasmid pSVc21 (A to C) or b-globin RNAs from the plasmid pbG-CMV (D to I). In situ labeled RNA is shown in green, whereas anti-SC-35
labeling is shown in red. In transfected cells SC-35-containing speckles often became more dispersed and less numerous whereas the weak anti-SC-35
staining in between speckles becames more predominant. Both intron-containing HIV-1 RNAs and intron-containing b-globin RNAs localized to areas
containing weak anti-SC-35 staining, while little staining was seen in strongly fluorescing speckles. IP, Intron probe; BGP, b-globin probe.
FIG. 3. HIV-1 RNAs and the Rev protein localize to the same areas of the nucleoplasm. Confocal micrographs showing localization of the Rev
protein and HIV-1 RNAs in COS cells transfected with pSVc21. Rev staining is shown in red and the RNA staining is shown in green. Overlays
of green and red images are shown in the panels at the bottom of the figure. The first and second columns show cells which have been
hybridized using the intron probe (IP). The cells shown in the third and fourth columns have been hybridized using the exon probe (EP).
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FIG. 4. Double labeling of HIV-1 RNAs and SC-35. Staining by the intron probe (IP) or the exon probe (EP) is shown in green, while anti-SC-35 staining is shown
in red. Overlays of green and red images are shown at the bottom. For each image a magnification of the boxed region is shown to the right. Note that HIV-1 RNAs
localize to areas of the nuclei containing weakly labeled SC-35, whereas little staining is seen in intensely fluorescing speckles. (A) Confocal micrographs of COS
cells transfected with pSVc21 (rev1) or pSVc21B (rev2). (B) Confocal micrographs of HeLa cells transfected with pSVc21. The arrows in a to c point to individual
speckles in order to ease the comparison. (C) Confocal micrograph of primary human CD41 lymphocytes infected with primary HIV-1 patient isolates.
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speckles which may represent sites of mRNA processing
(see Discussion). In order to investigate the relative dis-
tribution between SC-35 and HIV-1 RNAs produced in the
transfected COS cells, double labeling using the anti-
SC-35 Mab in combination with the HIV-1 RNA-specific
probes was carried out.
In cells which had been double labeled for RNAs and
SC-35, intensely labeled speckles and weaker SC-35
staining could clearly be distinguished. Also, the anti-
SC-35 staining in hybridized cells were virtually the same
as that seen in cells which had not been subjected to the
hybridization procedure (not shown).
In the majority of cells examined the nuclear RNA
staining was detected roughly in the same areas
which contained anti-SC-35 staining (Fig. 4). One ex-
ception, however, was the staining detected by the
intron probe in cells transfected with the rev2 plasmid
pSVc21B (Figs. 4Ag to 4Ai). As mentioned above, the
RNA staining in this case was very abundant and
dispersed throughout the nuclei, making it difficult to
detect any nonrandom relationship between labeled
RNAs and SC-35. In the other cases, though, a non-
random relationship between HIV-1 RNAs and SC-35
was detected. First, HIV-1 RNA staining did not ac-
cumulate in intensely labeled speckles. Instead, the
HIV-1 RNAs mostly localized in between speckles in
areas containing weak anti-SC-35 staining. Second, in
several of the cells examined, HIV-1 RNAs appeared
to localize at the periphery of speckles, whereas little
RNA staining was seen in the interior of these do-
mains. The RNA localization observed was not unique
to transfected COS cells (Fig. 4A), as the same rela-
tion between RNA and SC-35 staining was also seen
in transfected HeLa cells (Fig. 4B) and in primary
human lymphocytes infected with primary HIV-1 iso-
lates (Fig. 4C).
A proportion of the transfected COS cells (between
30 and 50%) exhibited an anti-SC-35 staining pattern
which was different from that seen in untransfected
cells (Figs. 5A to 5C). In these cells the number of
intensely fluorescing speckles was often reduced,
whereas the weaker anti-SC-35 staining appeared
more predominant. Also, in these cells the RNA stain-
ing colocalized with weak anti-SC-35 staining,
whereas little RNA staining was seen in the remaining,
strongly fluorescing, speckles.
Double labeling of intron-containing b-globin RNAs
and SC-35
In order to determine whether the localization ob-
served for incompletely spliced HIV-1 RNAs were differ-
ent from that of other intron-containing RNAs, double
labeling of SC-35 and transiently expressed b-globin
RNAs was performed. For this experiment COS cells
were transfected with the plasmid pbG-CMV (Chang and
Sharp, 1989) from which the second intron of the b-globin
gene is transcribed. The transfected cells were fixed in
paraformaldehyde 40 h after transfection and then sub-
jected to double labeling using the anti-SC-35 Mab and
a digoxigenin-labeled probe targeted to the intron region
of the expressed b-globin RNAs. In most cells which
stained positive for b-globin RNA, SC-35 appeared to
have redistributed in a manner similar to that observed in
some of the pSVc21-transfected cells (Figs. 5D to 5F). As
for HIV-1 RNAs the intron-containing b-globin RNAs also
predominantly localized to weak anti-SC-35 staining,
whereas no accumulation of RNAs in SC-35-containing
speckles was seen. However, the changes in SC-35
distribution in pbG-CMV-transfected cells were fre-
quently more dramatic than those in pSVc21-transfected
cells, and in some cases SC-35 appeared to have redis-
tributed completely from speckles to areas containing
b-globin RNAs (Figs. 5G to 5I).
DISCUSSION
The in situ labeling procedure used in this study was
optimized in order to perform simultaneous detection of
RNAs and proteins in fixed cells. Using this protocol it
was demonstrated for the first time that HIV-1 RNAs and
Rev localize to the same areas of the nucleoplasm. Using
the same procedure it was next shown that HIV-1 RNAs
distribute to areas containing weakly labeled SC-35.
In cells transfected with the rev-negative plasmid
pSVc21B the nuclear staining detected using the intron
probe was stronger and more abundant than the staining
detected in pSVc21-transfected cells in parallel experi-
ments. This observation is consistent with a recent study
showing that a subpopulation of diffusely labeled intron-
containing HIV-1 RNAs accumulate in the nuclei in the
absence but not in the presence of Rev (Zhang et al.,
1996). It may be tempting to assume, as was done in the
report by Zhang et al., that the excess intron-containing
RNAs found in rev-negative cells represent incompletely
spliced HIV-1 RNAs which would have been exported to
the nucleus if Rev had been present. However, a recent
study has presented evidence that only newly tran-
scribed HIV-1 RNAs are subject to Rev-mediated trans-
port (Iacampo and Cochrane, 1996). Thus, the strong
nuclear RNA signal detected in rev-negative cells may, in
part, represent a pool of RNAs which have entered a
dead-end pathway where Rev can no longer act. The
observation that the exon probe did not hybridize well to
the excess nucleoplasmic HIV-1 RNAs in Rev-negative
cells further underscores the uncertainty regarding this
nuclear HIV-1 RNA. Although we are currently unable to
explain the different staining by the exon and intron
probes in rev-negative cells, it should be noted that this
observation is consistent with the finding by Zhang et al.
that an intron-specific probe, but not a splice-junction
probe, hybridized to nuclear HIV-1 RNAs in experiments
similar to those performed in the present study (Zhang et
al., 1996).
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In cells transfected with pSVc21 no apparent differ-
ence was observed between the nuclear staining de-
tected by the intron and the exon probes. This finding
disagrees with the results obtained in a previous report
which showed that completely spliced HIV-1 RNAs pro-
duced in transfected HeLa cells concentrated in clusters
which contained the splicing factor SC-35 (Berthold and
Maldarelli, 1996). The failure in the present study to
detect such clusters by using the exon probe was not
due to differences in the cell lines used as a similar
staining pattern for exon-containing HIV-1 RNAs was
seen both in transfected COS cells and in transfected
HeLa cells. The reason for this discrepancy is therefore
not known.
Based on morphological studies which indicate that
newly synthesized RNAs mainly are present in PFs and
not in IGCs (Bachellerie et al., 1975; Fakan, 1994; Fakan
and Bernhard, 1971; Fakan and Nobis, 1978; Wansink et
al., 1993) and on experiments which suggest that splicing
occurs before or shortly after the release of pre-mRNAs
from the transcription site (Bauren and Wieslander, 1994;
Beyer and Osheim, 1991; McCracken et al., 1997), it has
been proposed that speckles function as storage or
assembly sites for splicing complexes and that splicing
components are recruited from speckles to sites of tran-
scription in order to carry out splicing. Consistent with
this model is the dynamic nature of IGCs, which is
revealed by the dramatic changes in appearance of
these domains upon inhibition of RPII (Spector, 1993) or
by the reorganization of splicing components to tran-
scription sites in transfected or adenovirus-infected cells
(Bridge et al., 1995; Huang and Spector, 1996; Jimenez-
Garcia and Spector, 1993; Pombo et al., 1994). Recently
the dynamics of speckles was visualized directly in living
cells using the green fluorescent protein (GFP) fused to
the splicing factor SF2/ASF (Misteli et al., 1997). In this
study an ongoing activity at the periphery of speckles
was seen which involved formation and retraction of
extensions in addition to dissociation and association of
small particles. In the same study it was also demon-
strated that induction of highly expressed genes in GFP-
SF2/ASF-containing cells resulted in the formation of
trails emerging from speckles toward the site of tran-
scription.
Thus, in the case of anti-SC-35-labeled cells which
were analyzed in the present study, strongly labeled
speckles could represent nuclear domains where splic-
ing factors are stored and would therefore not be ex-
pected to contain pre-mRNAs. Weak anti-SC-35 staining,
on the other hand, may represent splicing factors which
have been recruited from speckles and that are directly
involved in pre-mRNA splicing. The finding that both
HIV-1 RNAs and the Rev protein predominantly localize
to areas containing weak anti-SC-35 staining therefore
suggests that Rev interacts with HIV-1 RNAs at sites of
pre-mRNA splicing. This would also be consistent with
genetic and in vitro studies showing that early events in
spliceosome assembly are necessary in order for Rev to
mediate transport of incompletely spliced RNAs (Chang
and Sharp, 1989; Hammarskj¨old et al., 1994; Lu et al.,
1990; Stutz and Rosbash, 1994). In addition, this conclu-
sion is supported by the recent study showing that only
nascent HIV-1 pre-mRNAs are subject to Rev-mediated
transport (Iacampo and Cochrane, 1996).
The redistribution of SC-35 to areas containing tran-
siently expressed RNAs which was seen in some of the
transfected cells (Fig. 5) most likely resulted from over-
expression of RNAs in these cells. A similar finding was
made in a previous report which demonstrated that tran-
siently expressed RNAs containing functional splice
sites caused a redistribution of splicing factors from
speckles to the sites of transcription (Huang and Spec-
tor, 1996). The reason only some of the transfected COS
cells exhibited such redistribution, whereas reorganiza-
tion of SC-35 was seen in most COS cells transiently
producing b-globin RNAs, is not clear. It could be that the
splice sites present in b-globin pre-mRNAs promote re-
cruitment of splicing factors more efficiently than the
suboptimal splice sites present in HIV-1 RNAs. Alterna-
tively, the differences seen may be due to differences in
expression levels. Despite this difference, however, the
distribution of HIV-1 RNAs and b-globin RNAs was sim-
ilar. Both RNAs localized to weak anti-SC-35 staining
patterns, whereas little staining was seen in SC-35-con-
taining speckles.
Since the HIV-1 RNAs are detected at putative sites of
pre-mRNA transcription and splicing the present study
does not provide any evidence to support the hypothesis
that incompletely spliced HIV-1 RNAs are directed into a
nuclear compartment physically separate from the splic-
ing apparatus prior to Rev-mediated nucleocytoplasmic
transport. CRS elements, which have been proposed to
be involved in such redirection of HIV-1 RNAs (Berthold
and Maldarelli, 1996; Mikaelian et al., 1996), may never-
theless play a role in sequestration of incompletely
spliced HIV-1 RNAs at some stage during mRNA pro-
cessing. Thus, features both in the HIV-1 pre-mRNA and
in the Rev protein may serve to facilitate Rev–RRE inter-
action at some point between transcription and splicing.
MATERIALS AND METHODS
Cells and transfection
COS cells were grown on 12-mm polylysine-coated
coverslips in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% fetal calf serum. These cells were
transfected with 40 ng plasmid DNA per coverslip using
the DEAE–dextran method. HeLa cells were grown in
60-mm culture dishes in Iscove’s modified Dulbecco’s
medium supplemented with 10% fetal calf serum. These
cells were transfected with 1 mg plasmid DNA per tissue
culture plate using a calcium phosphate protocol (Øyan
et al., 1993). One day later, HeLa cells were trypsinized
and transferred to coverslips. At 24 to 40 h after trans-
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fection HeLa cells or COS cells were washed briefly in
phosphate-buffered saline (PBS), pH 7.2, and fixed for 20
min at room temperature (RT) in PBS containing 4%
paraformaldehyde. After fixation the cells were stored in
methanol at 220°C.
Infection of peripheral blood mononuclear cells
(PBMCs)
PBMCs were obtained by Ficoll–Isopaque gradient
separation (Lymphoprep Nycomed AS, Oslo, Norway) of
citrate anticoagulated venous blood from healthy HIV-1-
seronegative blood donors. CD41 T cells (CD4 cells)
were positively selected using magnetic beads (Dyna-
beads, Dynal AS, Oslo, Norway) as previously described
(Brinchmann et al., 1991). The CD4 cells were infected in
vitro using primary HIV-1 isolates obtained by coculture
of PBMCs from HIV-1-seropositive individuals and PHA-
stimulated PBMCs from healthy blood donors as previ-
ously described (Fenyo et al., 1988).
Activation of the in vitro infected CD4 cells was achieved
by immobilized anti-CD3 antibody (American Type Culture
Collection (ATCC), clone OKT3), at a concentration of 10
mg/ml coated onto the flat bottom of culture plates (Nunc,
Copenhagen, Denmark). The cells were cultured in RPMI
medium supplemented with 5 U/ml of recombinant inter-
leukin-2 (IL-2, Amersham, England) and 10% fetal calf se-
rum (FCS, Gibco Life Sciences).
Six days after infection, cytospin preparations of 1.5 3
105 cells from productively infected cell cultures were
fixed for 30 min in PBS containing 4% paraformaldehyde,
air dried, and stored at 220°C in methanol.
Plasmids
pSVc21 was a gift from W. A. Haseltine (Dana Farber
Cancer Institute, Boston, Massachusetts). It contains the
infectious HIV-1 HXBc2 proviral DNA clone and the SV-40
origin of replication. pSVc21B has a frame shift mutation
in the second exon of the rev gene. It was generated by
filling in a unique BamHI site present in pSVc21. pbG-
CMV, which was used to express b-globin RNAs, was a
gift from P. A. Sharp and has been described previously
(Chang and Sharp, 1989).
Probe preparation
Digoxigenin-labeled RNA probes were generated us-
ing an in vitro transcription kit (Boehringer Mannheim).
The intron probe was transcribed from a plasmid con-
taining a 2006-bp fragment of the HIV-1 genome (nucle-
otides 6127 to 8133 in GenBank locus HIVHXB2CG) using
the SP6 RNA polymerase. The exon probe was tran-
scribed from a plasmid containing the 351-bp cDNA
sequence of the HIV-1 rev gene using T3 RNA polymer-
ase. The probe targeted to the b-globin intron was tran-
scribed from a plasmid containing nucleotides 934 to
1450 present in the second intron of the rabbit b-globin
gene (GenBank locus RABHBBB1B1).
In situ hybridization and immunofluorescent labeling
The in situ hybridization protocol used was a modifi-
cation of a previously described procedure (Tautz and
Pfeifle, 1989). The hybridization mixture contained 50%
formamide, 53 SSC (SSC: 150 mM NaCl, 15 mM sodium
citrate, pH 7.0), 0.1 mg/ml yeast tRNA, 50 mg/ml heparin,
0.1% Tween 20, and 70 mM citric acid. Before hybridiza-
tion the coverslips were placed sequentially in 70%
methanol in PBT (PBS containing 0.1% Tween 20) at RT
for 5 min, 30% methanol in PBT at RT for 5 min, PBT at RT
for 10 min, and 50% hybridization wash (hybridization
mixture containing no tRNA or heparin) in PBT at RT for
5 min. Prehybridization and hybridization were carried
out by inverting a coverslip with fixed cells over 25 ml
hybridization mixture on parafilm. Prehybridization was
performed for 30 min at 60°C in a humidified chamber.
Coverslips were then moved to hybridization mixture
containing 0.5 ng/ml digoxigenin-labeled probe and in-
cubated for another 4 h in the humidified chamber at
60°C. After hybridization the cells were washed twice in
hybridization wash for 10 min at 60°C, once in 50%
hybridization wash in PBT for 10 min at RT, and then
twice for 10 min at RT in PBT.
Simultaneous detection of the digoxigenin-labeled
probe and one of the indicated proteins was performed
as follows. Nonspecific binding of antibodies was
blocked by incubating coverslips in blocking solution
(PBS containing 0.5% bovine serum albumin) for 10 min
at RT. Incubation with primary antibodies was then per-
formed at RT for 40 min. Primary antibodies used were
affinity-purified IgG antibodies raised in sheep against
digoxigenin (Boehringer Mannheim), the monoclonal an-
tibody (Mab) 8E7 (Kalland et al., 1994b), which binds to
the HIV-1 Rev protein, and the anti-SC-35 Mab (Fu and
Maniatis, 1990), which binds to the non-snRNP splicing
factor SC-35. In the case of double labeling of Rev and
mRNAs the anti-digoxigenin antibodies were diluted
1:100 in tissue culture media containing the 8E7 Mab.
When double labeling of mRNAs and SC-35 was carried
out, the anti-digoxigenin antibody and the SC-35 Mab
were diluted 1:100 in blocking solution. After incubation
with primary antibodies the cells were washed twice in
PBS and then incubated for 40 min at RT with secondary
antibodies. Secondary antibodies were fluorescein iso-
thiocyanate-conjugated (FITC) anti-sheep IgG antibodies
raised in donkey (Sigma) and biotin-conjugated anti-
mouse IgG antibodies raised in rabbit (Dacopatts,
Glostrup, Denmark). Both secondary antibodies were
diluted 1:100 in blocking solution. After incubation with
secondary antibodies the cells were washed twice in
PBS and then incubated for 20 min with Texas red-
conjugated streptavidin (Pierce) diluted 1:200 in blocking
solution. The cells were then washed four times in PBS,
dipped quickly in water, and mounted on slides in 7 ml
SlowFade (Molecular Probes Inc.).
The digoxigenin-labeled probes were specific for
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HIV-1 mRNA as hybridization signal was detected only in
transfected cells and not in neighboring untransfected
cells (see Fig. 2). No hybridization signal was detected
when cells were treated with 100 mg/ml RNase A for 30
min at 37°C in PBS prior to hybridization and no reduc-
tion in hybridization signal was seen when cells were
treated with PBS containing 5 mM MgCl2 and 100 U/ml
DNase I for 30 min at 37°C prior to hybridization (data not
shown).
Microscopy
Conventional fluorescent microscopy was performed
with a Nikon Microphot-SA microscope using a 40X
objective. Cells were photographed with AGFA APX 100
black and white film using the Nikon HFX-DX system.
Confocal microscopy was carried out using the Bio-
Rad MRC 1000 system attached to a Zeiss Axiovert 100
microscope with an 100X oil immersion objective. The
FITC and Texas red fluorochromes were independently
recorded following argon ion laser excitation at wave-
lengths of 488 and 529 nm, respectively. Five confocal
images of the cells were recorded at 0.18 mm per vertical
step and each of the series was projected onto a single
plane using an optical brightness algorithm. Pseudo-
coloring of images and generation of overlays were per-
formed using a Macintosh computer and the Adobe
PhotoShop program.
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